Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksERGO.L Regulatory News (ERGO)

  • There is currently no data for ERGO

Block Listing Six Monthly Return

2 Jan 2019 07:00

RNS Number : 7694L
Ergomed plc
02 January 2019
 

BLOCK LISTING SIX MONTHLY RETURN

 

 

Date: 2 January 2019

 

Name of applicant:

Ergomed plc

Name of scheme:

Ergomed plc Long Term Incentive Plan

Period of return:

From:

2 July 2018

To:

31 December 2018

Balance of unallotted securities under scheme(s) from previous return:

1,800,000 (original admission)

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

nil

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

55,000

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

1,745,000

Number and class of securities originally admitted and the date of admission

1,800,000 ordinary shares of 1p each - 2 July 2018

Total number of securities in issue at the end of the period

45,016,438 ordinary shares of 1p each

 

Name of contact:

Nick Blech - Deputy CFO

Telephone number of contact:

+44 (0)7768 547372

 

 Enquiries:

Ergomed plc

Tel: +44 (0) 1483 503205

Stephen Stamp (Chief Executive Officer)

Stuart Jackson (Chief Financial Officer)

 

Numis Securities Limited

Tel: +44 (0) 20 7260 1000

Michael Meade / Freddie Barnfield (Nominated Adviser)

James Black (Broker)

 

Consilium Strategic Communications - for UK enquiries

Tel: +44 (0) 20 3709 5700

Chris Gardner / Mary-Jane Elliott

Matthew Neal / Olivia Manser

 

ergomed@consilium-comms.com

MC-Services - for Continental European enquiries

Tel: +49 211 5292 5222

Anne Hennecke

 

About Ergomed plc

Ergomed provides specialist services to the pharmaceutical industry spanning all phases of clinical development, post-approval pharmacovigilance and medical information. Ergomed's fast-growing, profitable services offering encompasses a complete suite of specialist pharmacovigilance solutions, integrated under the PrimeVigilance brand, in addition to a full range of high quality contract research and trial management services (CRO). Leveraging its CRO expertise, Ergomed also has a drug development portfolio of co-development partnerships and wholly-owned programmes. For further information, visit: http://ergomedplc.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BLRFEWFWAFASEEE
Date   Source Headline
1st Jul 20197:00 amRNSTotal Voting Rights & Block Listing Return
25th Jun 20197:00 amRNSDirector/PDMR Shareholding
19th Jun 20197:00 amRNSShare Options
18th Jun 20193:04 pmRNSBoard Appointment
18th Jun 20192:59 pmRNSResult of AGM
13th Jun 20197:00 amRNSDirector/PDMR Shareholding
10th Jun 20197:00 amRNSPDMR Dealing
4th Jun 20197:00 amRNSAppointment of CFO
3rd Jun 20197:00 amRNSTotal Voting Rights
20th May 20196:30 pmRNSHolding(s) in Company
17th May 20197:00 amRNSNotice of AGM and Annual Report
16th May 20197:01 amRNSHolding(s) in Company
16th May 20197:00 amRNSTrading Update
9th May 201911:15 amRNSHoldings in Company
3rd May 20191:08 pmRNSHolding(s) in Company
23rd Apr 20197:00 amRNSErgomed's PrimeVigilance receives Queen's Award
12th Apr 20197:00 amRNSEarn-Out Shares and PDMR Dealing
10th Apr 20197:00 amRNSPreliminary Results
2nd Apr 20197:00 amRNSNotice of Preliminary Results
1st Apr 20197:00 amRNSRoy Ovel appointed as Chief Commercial Officer
1st Apr 20197:00 amRNSTotal Voting Rights
11th Mar 20191:52 pmRNSChristopher Collins
1st Mar 20197:00 amRNSTotal Voting Rights
13th Feb 20197:00 amRNSProposed Board and Management Changes
1st Feb 201911:31 amRNSExercise of Options & Issue of Equity
31st Jan 20197:00 amRNSErgomed 2018 Trading Update
23rd Jan 20197:00 amRNSBoard and Management Changes
21st Jan 20197:00 amRNSHoldings in Company
4th Jan 201910:34 amRNSDirectors' Dealing
2nd Jan 20197:00 amRNSBlock Listing Six Monthly Return
27th Nov 20181:50 pmRNSHoldings in Company
5th Nov 20182:03 pmRNSHoldings in Company
1st Nov 20182:44 pmRNSErgomed issue of shares
2nd Oct 20182:47 pmRNSBoard Changes
19th Sep 20187:00 amRNSInterim Results
14th Sep 20187:00 amRNSNotice of Interim Results
16th Aug 20184:36 pmRNSHoldings in Company
16th Jul 20185:31 pmRNSChange of auditor
4th Jul 201811:11 amRNSIssue of shares
3rd Jul 20187:00 amRNSAward of share options
2nd Jul 20187:00 amRNSBoard appointment
28th Jun 20187:00 amRNSTrading Update
27th Jun 201811:52 amRNSBlock listing application
21st Jun 20189:11 amRNSExercise of options
15th Jun 20183:14 pmRNSChange of Registered Office
12th Jun 20183:55 pmRNSResults of 2018 Annual General Meeting
25th May 20187:00 amRNSKey hire in pharmacoepidemiology services
24th May 20184:00 pmRNSHolding(s) in Company
21st May 20183:35 pmRNSNotice of AGM
2nd May 20187:00 amRNSHoldings in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.